Status:
COMPLETED
Brain Effects of Sacral Neuromodulation
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Urinary Tract Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Sacral neuromodulation (SNM) has become an accepted treatment for patients with refractory lower urinary tract dysfunction such as urgency frequency syndrome, urgency incontinence, non-obstructive chr...
Eligibility Criteria
Inclusion
- Patients with refractory lower urinary tract dysfunction scheduled for sacral neuromodulation
Exclusion
- Pregnancy
- Age \<18 years
- Claustrophobia
Key Trial Info
Start Date :
October 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00610064
Start Date
October 1 2005
End Date
June 1 2009
Last Update
February 5 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, University of Bern
Bern, Switzerland, 3010